Dr. David Kuttenkeuler works in the biotechnology/pharmaceuticals and chemistry practice groups. Over the past 15 years, Dr. Kuttenkeuler has conducted a large number of opposition and appeal proceedings before the European Patent Office as well as nullity and infringement proceedings before German and other European courts.

He has particular expertise in the fields of pharmaceuticals, immunology, microbiology, molecular genetics, medical antibodies and T-cell receptors, as well as plant biotechnology. Numerous patents of high commercial value for various biotechnology and pharmaceutical companies have been entrusted to him and his team at SKM-IP. Dr. Kuttenkeuler also has extensive experience in the field of plant variety protection. He regularly comments on the development of intellectual property rights in the field of life sciences and pharmaceuticals in various journals and platforms on current case law in Europe and the USA.

Dr. Kuttenkeuler supports his clients in all areas of intellectual property law. He attaches particular importance to comprehensive and far-sighted advice. He has successfully advised various biotech companies - in some cases since their foundation - on the development of their patent portfolios and patent strategies over many years. This includes support in freedom-to-operate (FTO) analyses, drafting and timing of patent applications, conducting grant proceedings, defending and attacking patent oppositions, as well as comprehensive advice and organization in due diligence projects and the negotiation of license agreements.

Dr. Kuttenkeuler studied biology at the Universities of Regensburg and Heidelberg. His subsequent scientific career includes a doctorate at the renowned German Cancer Research Center in Heidelberg, followed by a postdoctoral research stay at the Sanger Center in Cambridge, UK. His scientific work has been published in numerous publications, including Nature, Nature Immunology and EMBO.

David Kuttenkeuler is one of the five founders of SKM-IP.